Navigation Links
Possible biological control discovered for pathogen devastating amphibians
Date:8/26/2011

CORVALLIS, Ore. -- Zoologists at Oregon State University have discovered that a freshwater species of zooplankton will eat a fungal pathogen which is devastating amphibian populations around the world.

This tiny zooplankton, called Daphnia magna, could provide a desperately needed tool for biological control of this deadly fungus, the scientists said, if field studies confirm its efficacy in a natural setting.

The fungus, B. dendrobatidis, is referred to as a "chytrid" fungus, and when it reaches high levels can disrupt electrolyte balance and lead to death from cardiac arrest in its amphibian hosts. One researcher has called its impact on amphibians "the most spectacular loss of vertebrate biodiversity due to disease in recorded history."

The research, reported today in the journal Biodiversity and Conservation, was supported by the National Science Foundation.

"There was evidence that zooplankton would eat some other types of fungi, so we wanted to find out if Daphnia would consume the chytrid fungus," said Julia Buck, an OSU doctoral student in zoology and lead author on the study. "Our laboratory experiments and DNA analysis confirmed that it would eat the zoospore, the free-swimming stage of the fungus."

"We feel that biological control offers the best chance to control this fungal disease, and now we have a good candidate for that," she said. "Efforts to eradicate this disease have been unsuccessful, but so far no one has attempted biocontrol of the chytrid fungus. That may be the way to go."

The chytrid fungus, which was only identified in 1998, is not always deadly at low levels of infestation, Buck said. It may not be necessary to completely eliminate it, but rather just reduce its density in order to prevent mortality. Biological controls can work well in that type of situation.

Amphibians have been one of the great survival stories in Earth's history, evolving about 400 million years ago and surviving to the present while many other life forms came and went, including the dinosaurs. But in recent decades the global decline of amphibians has reached crisis proportions, almost certainly from multiple causes that include habitat destruction, pollution, increases in ultraviolet light due to ozone depletion, invasive species and other issues.

High on the list, however, is the chytrid fungus that has been documented to be destroying amphibians around the world, through a disease called chytridiomycosis.

Its impact has been severe and defied various attempts to control it, even including use of fungicides on individual amphibians. Chytridiomycosis has been responsible for "unprecedented population declines and extinctions globally," the researchers said in their report.

"About one third of the amphibians in the world are now threatened and many have gone extinct," said Andrew Blaustein, a professor of zoology, co-author on this study and an international leader in the study of amphibian decline.

"It's clear there are multiple threats to amphibians, but disease seems to be a dominant cause," he said.

Although they have survived for hundreds of millions of years, amphibians may be especially vulnerable to rapid environmental changes and new challenges that are both natural and human-caused. They have a permeable skin, and exposure to both terrestrial and aquatic environments.

Because of this, OSU researchers said, other animals such as mammals, birds and fish have so far not experienced such dramatic population declines.


'/>"/>

Contact: Andrew Blaustein
blaustea@science.oregonstate.edu
541-737-9869
Oregon State University
Source:Eurekalert

Related biology news :

1. Link possible between pet food contamination and baby formula contamination
2. Inherited genetic cause, possible treatment found for complex lung disorder
3. Argonne scientists discover possible mechanism for creating handedness in biological molecules
4. Vitamin E shows possible promise in easing chronic inflammation
5. Nanotechnology culture war possible, says Yale study
6. Rice University study finds possible clues to epilepsy, autism
7. Pitt, NETL researchers report molecular chain reaction thought to be impossible
8. MU researcher identifies possible genetic causes of borderline personality disorder
9. Our unconscious brain makes the best decisions possible
10. Promising new drug being evaluated as possible treatment option for fragile X syndrome
11. Control of blood vessels a possible weapon against obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 More than $4.3 million was ... Medals dinner ( DHMD ). The gala was held at the ... York City and honored Alan Alda ... to health and medicine and the public understanding of science. ... 2006, the event has raised $40 million for the Laboratory,s ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the ... and a beautiful technology experience. All three tenets were on display at the 2nd ... leaders from over 40 sponsor, CRO and site organizations to discuss innovation and the ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
Breaking Biology Technology: